Jie Ouyang
State Key Laboratory Of Traditional Chinese Medicine Syndrome
Guangzhou, 510405, China
Guangzhou, 510405, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Corrigendum to "Tongfu-Xingshen capsule ameliorates ischemic stroke by inhibiting pyroptosis-mediated neuroinflammation" [J. Ethnopharmacol. 366 (2026) 121565].
Journal: Journal of ethnopharmacology
Published: June 10, 2026
Malignant biological behaviors of triple-negative breast cancer cells mitigated by daphnetin through suppression of the PI3K-AKT-mTOR signaling cascade and activation of autophagy.
Journal: RSC medicinal chemistry
Published: March 25, 2026
Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 23, 2026
Tongfu-Xingshen Capsule ameliorates ischemic stroke by inhibiting pyroptosis-mediated neuroinflammation.
Journal: Journal of ethnopharmacology
Published: January 22, 2026
Advancements in Dalpiciclib for the Treatment of Breast Cancer Patients: A Review.
Journal: Breast cancer (Dove Medical Press)
Published: March 22, 2025
MRI-based multimodal AI model enables prediction of recurrence risk and adjuvant therapy in breast cancer.
Journal: Pharmacological research
Published: March 02, 2025
Efficacy and safety of eribulin plus gemcitabine as second-line treatment for recurrent HER2-negative breast cancer: a phase II, single-arm, open-label trial.
Journal: Communications medicine
Published: February 19, 2025
Anti-tumor activity of beauvericin: focus on intracellular signaling pathways.
Journal: Mycotoxin research
Published: March 17, 2024
Recent advances and prospects of metal-organic frameworks in cancer therapies.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: November 13, 2023
Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway.
Journal: International journal of biological sciences
Published: May 15, 2023
Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study.
Journal: Breast cancer research : BCR
Published: March 28, 2023
Erratum: Author correction to "The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304].
Journal: Acta pharmaceutica Sinica. B
Published: March 27, 2023
Last Updated: 09/26/2026